Development

Articles

Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

Week Of April 5, 2010: Company And People Notes: Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

As the industry continues to evolve, do we know where we're headed?

Unconventional Communication

The authors examined the disintegration and dissolution profiles of propranolol and rofecoxib tablets overencapsulated with standard hard-gelatin capsules and with capsules specifically designed for double-blind clinical trials.

The Effect of Overencapsulation on Disintegration and Dissolution

Jane Wan is a freelance writer based in Singapore.

As demand for global vaccine development and production grows, all eyes are turning to Asia.

Report from Asia

Industry Pipeline

Jim Greenwood is president and CEO of the Biotechnology Innovation Organization (BIO). He represented Pennsylvania’s 8thÂ district in the US House of Representatives from 1993 to 2005.

The BIO convention, and healthcare reform, could re-energize biotech.

Delivering on the Promise of Biotechnology

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and types of spending made in 2009 and planned for 2010.

Spending More or Less, and on What?

Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.

Moving to the Next Level in Biomanufacturing

Biotechnology company Genzyme reported that FDA notified the company that it intends to take enforcement action to ensure that products are made in compliance with good manufacturing practice (GMP) regulations.

Ingredients